Patients with rheumatoid arthritis who switched biologics incurred higher costs than patients who persisted on biologics. Etanercept appeared to be associated with the lowest costs.
Hiangkiat Tan, MS, BSPharm
Advertisement
Articles by Hiangkiat Tan, MS, BSPharm
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
Counseling Vitiligo Patients on Time to Repigmentation
4
5 August FDA Approvals Marked by Novelty, Pushback
5